Participated · Seed · Jul 2026

Rosota develops next-generation surgical robots that embed AI trained on surgical data to understand and assist in real-time clinical situations. Its core asset is a proprietary data-collection infrastructure that captures surgical video, medical-device motion, and sensor data in real time, then anonymizes and integrates those signals for AI training. The company was spun out of the MediSC lab at Seoul National University Hospital and is led by CEO Seo Ye-chan with cofounders Choi Min-woo and Lee Dong-ho. Rosota positions itself to move beyond teleoperated robots by creating what it calls an "AI-native" surgical system that can learn and support surgeons’ decision-making. With the newly raised 1.5 billion won seed round, the company plans to further develop its data platform, train its AI models, and grow its clinical collaboration network. The team emphasizes a multidisciplinary approach combining clinical problem definition and robotic systems implementation.